Core Scientific FY2025 EPS Forecast Reduced by Roth Capital

Core Scientific, Inc. (NASDAQ:CORZFree Report) – Equities researchers at Roth Capital lowered their FY2025 earnings estimates for shares of Core Scientific in a research note issued to investors on Tuesday, January 7th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings per share of ($0.30) for the year, down from their previous forecast of ($0.29). Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.50 per share. Roth Capital also issued estimates for Core Scientific’s Q4 2025 earnings at ($0.01) EPS and FY2026 earnings at $0.33 EPS.

CORZ has been the topic of a number of other research reports. Jefferies Financial Group initiated coverage on shares of Core Scientific in a report on Monday, October 28th. They issued a “buy” rating and a $19.00 price target on the stock. Canaccord Genuity Group initiated coverage on shares of Core Scientific in a research note on Monday, September 23rd. They issued a “buy” rating and a $16.00 price objective for the company. Macquarie lifted their price objective on shares of Core Scientific from $16.00 to $19.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th. B. Riley lifted their price objective on shares of Core Scientific from $16.00 to $17.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Finally, Needham & Company LLC lifted their price objective on shares of Core Scientific from $17.00 to $18.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Thirteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Core Scientific presently has a consensus rating of “Buy” and a consensus price target of $18.46.

Get Our Latest Research Report on Core Scientific

Core Scientific Trading Down 0.5 %

NASDAQ:CORZ opened at $14.05 on Thursday. The stock has a market capitalization of $3.92 billion and a PE ratio of -2.60. The firm’s 50 day moving average is $15.62 and its 200 day moving average is $12.56. Core Scientific has a 12 month low of $2.61 and a 12 month high of $18.63.

Institutional Investors Weigh In On Core Scientific

A number of hedge funds and other institutional investors have recently bought and sold shares of CORZ. Bank of New York Mellon Corp grew its holdings in Core Scientific by 3,236.0% in the second quarter. Bank of New York Mellon Corp now owns 674,043 shares of the company’s stock worth $6,269,000 after purchasing an additional 653,838 shares during the period. Principal Financial Group Inc. bought a new position in Core Scientific in the second quarter worth approximately $211,000. Rhumbline Advisers purchased a new position in Core Scientific during the second quarter valued at $2,233,000. Victory Capital Management Inc. purchased a new position in shares of Core Scientific during the 2nd quarter valued at about $175,000. Finally, Nicholas Investment Partners LP bought a new position in shares of Core Scientific in the second quarter worth approximately $2,589,000.

Insiders Place Their Bets

In other news, Director Yadin Rozov sold 105,000 shares of the company’s stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $18.11, for a total transaction of $1,901,550.00. Following the completion of the transaction, the director now directly owns 345,239 shares of the company’s stock, valued at approximately $6,252,278.29. This represents a 23.32 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Adam Taylor Sullivan sold 88,380 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $14.24, for a total transaction of $1,258,531.20. Following the transaction, the chief executive officer now directly owns 4,128,505 shares of the company’s stock, valued at approximately $58,789,911.20. This trade represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 348,241 shares of company stock valued at $5,436,802 over the last three months. Insiders own 32.00% of the company’s stock.

About Core Scientific

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

See Also

Earnings History and Estimates for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.